Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-11-06 5:12 pm Purchase | 2020-10-29 | 13D | Galecto, Inc. GLTO | ORBIMED ADVISORS LLC | 110,858 11.300% | 110,858 (New Position) | Filing History |
| 2020-10-22 8:40 pm Unchanged | 2020-10-22 | 13D | BELLUS Health Inc. BLU | ORBIMED ADVISORS LLC | 3,954,800 5.200% | 0 (Unchanged) | Filing History |
| 2020-10-13 9:14 pm Unchanged | 2020-10-13 | 13D | SpringWorks Therapeutics, Inc. SWTX | ORBIMED ADVISORS LLC | 7,406,307 15.500% | 0 (Unchanged) | Filing History |
| 2020-10-07 5:08 pm Purchase | 2020-10-02 | 13D | Arcutis Biotherapeutics, Inc. ARQT | ORBIMED ADVISORS LLC | 4,267,564 9.900% | 200,000 (+4.92%) | Filing History |
| 2020-10-06 5:16 pm Purchase | 2020-10-01 | 13D | ContextLogic Inc. LOGC | ORBIMED ADVISORS LLC | 137,566 13.000% | 21,307 (+18.33%) | Filing History |
| 2020-10-05 5:28 pm Purchase | 2020-09-25 | 13D | Graybug Vision, Inc. GRAY | ORBIMED ADVISORS LLC | 297,382 20.700% | 297,382 (New Position) | Filing History |
| 2020-10-05 5:27 pm Purchase | 2020-10-01 | 13D | Xtant Medical Holdings, Inc. XTNT | ORBIMED ADVISORS LLC | 72,810,381 94.800% | 58,796,060 (+419.54%) | Filing History |
| 2020-10-05 5:23 pm Purchase | 2020-09-25 | 13D | PMV Pharmaceuticals, Inc. PMVP | ORBIMED ADVISORS LLC | 6,589,330 14.700% | 6,589,330 (New Position) | Filing History |
| 2020-10-05 5:17 pm Purchase | 2020-09-25 | 13D | Prelude Therapeutics Incorporated PRLD | ORBIMED ADVISORS LLC | 14,805,377 33.900% | 14,805,377 (New Position) | Filing History |
| 2020-09-23 5:00 pm Sale | 2020-09-21 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 1,864,721 9.400% | -137,500 (-6.87%) | Filing History |
| 2020-09-18 5:12 pm Purchase | 2020-09-15 | 13D | RESTORBIO INC TORC | ORBIMED ADVISORS LLC | 5,513,015 28.100% | 682,628 (+14.13%) | Filing History |
| 2020-08-19 5:14 pm Sale | 2020-08-06 | 13G | ESSA Pharma Inc. EPIX | ORBIMED ADVISORS LLC | 1,177,483 4.100% | -294,370 (-20.00%) | Filing History |
| 2020-08-18 4:31 pm Purchase | 2020-08-10 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 5,810,525 20.900% | 5,810,525 (New Position) | Filing History |
| 2020-07-30 6:26 pm Unchanged | 2020-07-28 | 13D | Alpine Immune Sciences, Inc. ALPN | ORBIMED ADVISORS LLC | 3,816,206 16.000% | 0 (Unchanged) | Filing History |
| 2020-07-27 5:57 pm Purchase | 2020-07-17 | 13G | PANDION THERAPEUTICS INC PAND | ORBIMED ADVISORS LLC | 1,040,825 3.600% | 1,040,825 (New Position) | Filing History |
| 2020-07-16 5:12 pm Sale | 2020-07-14 | 13D | Alector, Inc. ALEC | ORBIMED ADVISORS LLC | 2,725,313 3.500% | -2,776,735 (-50.47%) | Filing History |
| 2020-07-13 4:20 pm Unchanged | 2020-07-10 | 13D | 89bio, Inc. ETNB | ORBIMED ADVISORS LLC | 2,002,221 11.900% | 0 (Unchanged) | Filing History |
| 2020-07-10 11:55 am Sale | 2020-07-07 | 13D | Alector, Inc. ALEC | ORBIMED ADVISORS LLC | 5,502,048 7.000% | -964,944 (-14.92%) | Filing History |
| 2020-07-06 5:57 pm Purchase | 2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN | ORBIMED ADVISORS LLC | 2,997,981 7.200% | 2,997,981 (New Position) | Filing History |
| 2020-07-01 5:31 pm Unchanged | 2020-06-30 | 13D | TELA Bio, Inc. TELA | ORBIMED ADVISORS LLC | 3,058,267 21.200% | 0 (Unchanged) | Filing History |